Simplifying Global Compliance
FDAnews Device Daily Bulletin
Transplant Genomics Picks Up Transplant Dx IP
July 16, 2014
Transplant Genomics (TGI) now has an exclusive license to patent rights co-owned by The Scripps Research Institute and Northwestern University that could form the basis for clinical tests to improve management of organ transplant recipients. TGI is planning to use the technology to develop and commercialize tests that use genomic markers of transplant graft status as part of program to detect and respond to early signs of graft injury in patients.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing